iBIO NEWS
Your source for the news and events happening in our communityiBIO NEWS
iBIO Crowns Champion in “Illinois BioGENEius Challenge” Student Competition
GRANT REPORT: Critical Federal Funding Opportunities Amidst Changing Landscape
A Year of Growth and Innovation: iBIO Leadership Reflects on 2024 Achievements
New Report Highlights Illinois Life Sciences Industry’s Remarkable Growth and Economic Impact
COMMUNITY NEWS
AbbVie to Acquire Alzheimer’s Drug Developer Aliada Therapeutics for $1.4 Billion
FDA Approves Iterum’s Novel Oral Antibiotic for Urinary Tract Infections
Breakthrough in Parkinson’s Treatment: Vanqua Bio’s VQ-101 Shows Promising Results
Astellas Invests in Future of Frontotemporal Dementia Treatment with AviadoBio Partnership
POLICY NEWS
ALL NEWS
iBIO Statement on President Trump’s Recent Executive Order Addressing Drug Pricing
iBIO recognizes the significance of the Trump Administration's recent Executive Order addressing...
GRANT REPORT: Critical Federal Funding Opportunities Amidst Changing Landscape
In partnership with G2G Consulting, iBIO is pleased to provide members with the March 2025...
Council on State Biotechnology Associations says NIH funds are a critical component of innovation ecosystem
“Today, the US biotech industry employs nearly 2.3 million people across the US and is making...
iBIO January Grants Report Highlights Expansive Funding Opportunities for Life Sciences Innovation
In partnership with G2G Consulting, we are please to provide the January 2025 Grants report,...
Xentria Secures Landmark Agreement with NYU for Cardiovascular Therapy Development
Chicago-based Xentria advances Illinois' position in life sciences innovation through strategic...
Capital Pulse: Flow Medical Secures $5M Seed Round, Including First-Ever UCM Ventures Investment
Flow Medical, a startup spun out of UChicago Medicine, has secured $5 million in seed funding,...
A Year of Growth and Innovation: iBIO Leadership Reflects on 2024 Achievements
As Illinois' life sciences industry continues its remarkable growth trajectory, iBIO President and...
The Growing Crisis of Antimicrobial Resistance: Meitheal Takes Action with XENLETA®
In a significant move addressing one of healthcare's most pressing challenges, Meitheal...
COUR Pharmaceuticals and Genentech Strike $900M+ Deal for Autoimmune Disease Treatment
COUR Pharmaceuticals has secured a strategic collaboration and licensing agreement with Genentech,...
New Report Highlights Illinois Life Sciences Industry’s Remarkable Growth and Economic Impact
The newly released TECONOMY/BIO report, "The U.S. Bioscience Economy: Driving Economic Growth and...